Sam Semenka
Analyst
Citi
Equibles does not estimate personal net worth.
About Sam Semenka
Sam Semenka is recorded as Analyst at Citi. Sam Semenka has spoken on 1 investor event across 1 company, most recently for SAB Biotherapeutics, Inc. on September 10, 2026. The companies whose calls Sam Semenka spoke on are classified in the Healthcare sector.
Sam Semenka on recent calls
“I'm one of the senior biotech analysts here at Citi, and it is my pleasure to be hosting SAB Bio at Citi's 2026 Biopharma Back-to-School Summit. I'm joined by Sam Raich, CEO, and Lucy Toh, CFO of SAB Bio.”
Affiliation history
-
Citi
Analyst
Transcript header (unverified)
Current